Testing with puromycin and amino acyl tRNAs that limit the rate of peptide chain extension.
With puromycin one can recognize when the synthesis of a given protein is dependent on amino acyl tRNA that is present in rate limiting amount. We demonstrate this use of puromycin by its interaction with another inhibitor, L-o-methylthreonine. L-o-methylthreonine lowers the Ile-tRNA concentration in the cell, thereby inhibiting synthesis of proteins containing isoleucine. In certain rabbits, the alpha hemoglobin chain has three isoleucyl residues and the beta chain none. L-o-methylthreonine thus inhibits alpha globin synthesis in intact reticulocytes from these rabbits. When puromycin and L-o-methylthreonine are used together, the two inhibitors synergize in inhibiting alpha globin synthesis. Hence, puromycin is a more effective inhibitor when the Ile-tRNA concentration is lowered. Cycloheximide and sodium fluoride have different modes of action from puromycin. Neither synergizes with L-o-methylthreonine; instead, the interaction is less than additive. We have found that beta chain synthesis in rabbit reticulocytes is more sensitive than alpha to inhibition by puromycin. This difference could reflect either differences in amino acid sequence or tRNA dependent limitations of beta chain elongation. The switch from fetal to adult hemoglobin in humans does not involve changes in limiting amino acyl tRNA because, for cord blood from infants of different developmental ages, the puromycin sensitivity of incorporation into gamma and beta chains remains constant.
D000818:Animals; D003513:Cycloheximide / Q000494:pharmacology; D004357:Drug Synergism; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D005459:Fluorides / Q000494:pharmacology; D005914:Globins / Q000096:biosynthesis*; D006801:Humans; D007532:Isoleucine / Q000378:metabolism; D046911:Macromolecular Substances; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects*; D011691:Puromycin / Q000494:pharmacology*; D012346:RNA, Transfer, Amino Acyl / Q000378:metabolism*; D011817:Rabbits; D013912:Threonine / Q000031:analogs & derivatives / Q000494:pharmacology
D046911:Macromolecular Substances; D012346:RNA, Transfer, Amino Acyl; D007532:Isoleucine; D013912:Threonine; D011691:Puromycin; D005914:Globins; D005319:Fetal Hemoglobin; D003513:Cycloheximide; D005459:Fluorides
J Theor Biol. 1974 Jan;43(1):211-25
4591738
Arch Biochem Biophys. 1968 Mar 20;124(1):306-13
4298495
J Mol Biol. 1965 Feb;11:358-72
14290351
Proc Natl Acad Sci U S A. 1964 Jun;51:1134-41
14215634
Proc Natl Acad Sci U S A. 1964 Apr;51:585-92
14166766
J Mol Biol. 1969 Jul 14;43(1):123-33
5811817
Biochim Biophys Acta. 1974 Jun 7;351(2):437-41
4407315
Proc Natl Acad Sci U S A. 1959 Dec;45(12):1721-9
16590564
Proc Natl Acad Sci U S A. 1961 Mar 15;47:247-61
13723017
Nature. 1976 Mar 4;260(5546):67-70
1264198
J Mol Biol. 1966 Oct 28;21(1):51-69
5969765
J Biol Chem. 1971 Jan 10;246(1):174-81
5541758
J Mol Biol. 1968 Aug 28;36(1):31-45
5760537
Genetics. 1974 Jan;76(1):99-108
4818267
Blut. 1958 Nov;4(5):241-9
13607582
J Biol Chem. 1974 Jul 25;249(14):4594-600
4843145
Ann N Y Acad Sci. 1974 Nov 29;241(0):223-31
4530654
Jinrui Idengaku Zasshi. 1967 Oct;12(2):55-61
4866959
J Mol Biol. 1966 Aug;19(1):91-108
5967288
Eur J Biochem. 1970 Sep;16(1):136-42
4917228
Arch Biochem Biophys. 1973 Oct;158(2):922-4
4782539
Biochim Biophys Acta. 1976 Dec 1;454(2):329-37
1033768
Biochemistry. 1967 Jun;6(6):1704-11
5340946
Eur J Biochem. 1975 Oct 15;58(2):339-50
1183442
J Mol Biol. 1968 Apr 14;33(1):315-8
5646650
Proc Natl Acad Sci U S A. 1975 Jan;72(1):258-62
1054502
Proc Natl Acad Sci U S A. 1969 Aug;63(4):1206-13
5260921
Proc Natl Acad Sci U S A. 1968 Apr;59(4):1349-55
5240035
J Biol Chem. 1972 Jun 10;247(11):3622-9
4624122
Hoppe Seylers Z Physiol Chem. 1966;347(4):207-11
5991669
Hoppe Seylers Z Physiol Chem. 1968 Aug;349(8):1073-5
5679924